Translating the Human Genome Project into prevention of myocardial infarction and stroke--getting close?
O'Donnell
Christopher J
CJ
D058927:5-Lipoxygenase-Activating Proteins; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000235:genetics*; D002352:Carrier Proteins / Q000037:antagonists & inhibitors / Q000235:genetics*; D006801:Humans; D016859:Lipoxygenase Inhibitors / Q000627:therapeutic use*; D008565:Membrane Proteins / Q000037:antagonists & inhibitors / Q000235:genetics*; D009203:Myocardial Infarction / Q000235:genetics / Q000517:prevention & control; D012307:Risk Factors; D020521:Stroke / Q000235:genetics / Q000517:prevention & control
D058927:5-Lipoxygenase-Activating Proteins; C548592:ALOX5AP protein, human; D002352:Carrier Proteins; D016859:Lipoxygenase Inhibitors; D008565:Membrane Proteins